tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PVLA Stock Latest News

Palvella Therapeutics price target raised to $70 from $30 at Cantor Fitzgerald
The FlyPalvella Therapeutics price target raised to $70 from $30 at Cantor Fitzgerald
13h ago
PVLA
Palvella Therapeutics Reports 2024 Financial Results and Updates
PremiumCompany Announcements
Palvella Therapeutics Reports 2024 Financial Results and Updates
15h ago
8K
PVLA
Palvella Therapeutics reports FY24 EPS ($7.83), consensus ($3.01)
PremiumThe Fly
Palvella Therapeutics reports FY24 EPS ($7.83), consensus ($3.01)
16h ago
PVLA
Palvella Therapeutics initiated with a Buy at Stifel
PremiumThe Fly
Palvella Therapeutics initiated with a Buy at Stifel
6d ago
PVLA
Palvella Therapeutics initiated with a Buy at JonesResearch
PremiumThe Fly
Palvella Therapeutics initiated with a Buy at JonesResearch
6d ago
PVLA
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
PremiumThe FlyTesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
25d ago
W
AL
Positive Outlook on Palvella Therapeutics: Buy Rating Backed by Promising QTORIN Rapamycin Potential
Premium
Ratings
Positive Outlook on Palvella Therapeutics: Buy Rating Backed by Promising QTORIN Rapamycin Potential
25d ago
PVLA
Palvella Therapeutics initiated with an Outperform at Scotiabank
Premium
The Fly
Palvella Therapeutics initiated with an Outperform at Scotiabank
25d ago
KRYS
PVLA
Palvella Therapeutics Enhances Investor Relations with New Presentation
PremiumCompany Announcements
Palvella Therapeutics Enhances Investor Relations with New Presentation
28d ago
8K
PVLA
Optimistic Buy Rating for Palvella Therapeutics Driven by Promising QTORIN Rapamycin Trials and Strategic Expertise
PremiumRatings
Optimistic Buy Rating for Palvella Therapeutics Driven by Promising QTORIN Rapamycin Trials and Strategic Expertise
1M ago
PVLA
Palantir initiated, Roku upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Palantir initiated, Roku upgraded: Wall Street’s top analyst calls
1M ago
CE
BAX
Canaccord starts Palvella Therapeutics with a Buy on lead programs’ potential
PremiumThe Fly
Canaccord starts Palvella Therapeutics with a Buy on lead programs’ potential
1M ago
PVLA
Palvella Therapeutics initiated with a Buy at Canaccord
PremiumThe FlyPalvella Therapeutics initiated with a Buy at Canaccord
1M ago
PVLA
Palvella Therapeutics to expand Phase 3 SELVA trial to include younger patients
Premium
The Fly
Palvella Therapeutics to expand Phase 3 SELVA trial to include younger patients
2M ago
PVLA
Palvella Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
Palvella Therapeutics initiated with a Buy at TD Cowen
2M ago
PVLA
Promising Potential of Palvella Therapeutics’ QTORIN Platform Drives Buy Rating
PremiumRatings
Promising Potential of Palvella Therapeutics’ QTORIN Platform Drives Buy Rating
2M ago
PVLA
Four new option listings and one option delisting on January 29th
PremiumThe Fly
Four new option listings and one option delisting on January 29th
2M ago
GOEV
JAVA
Palvella Therapeutics announces results from Phase 2 study of QTORIN
PremiumThe Fly
Palvella Therapeutics announces results from Phase 2 study of QTORIN
3M ago
PVLA
Palvella Therapeutics announces first patients dosed in Phase 2 TOIVA trial
PremiumThe Fly
Palvella Therapeutics announces first patients dosed in Phase 2 TOIVA trial
3M ago
PVLA
Wedbush hikes Apple target to high on Street: Morning Buzz
PremiumThe FlyWedbush hikes Apple target to high on Street: Morning Buzz
3M ago
X
MA
Progressive, EverQuote upgraded: Wall Street’s top analyst calls
Premium
The Fly
Progressive, EverQuote upgraded: Wall Street’s top analyst calls
3M ago
PGR
EVER
Palvella Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Palvella Therapeutics initiated with a Buy at H.C. Wainwright
3M ago
PVLA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >